Kevin J Weatherwax (Kevin Weatherwax)

Publication Activity (10 Years)

Years Active: 2021-2023
Publications (10 Years): 5

Top Topics

Randomized Controlled Trial

Drug Administration

Respiratory Syndrome Coronavirus

Top Venues

Journal of clinical and translational science

medRxiv : the preprint server for health sciences

This page only lists publications with an associated author ORCID identifier.

Publications

Misty Gravelin, Theophilus Nguyen, Madeleine Davies, Blair Richards, Jonathan Z Sexton, Kevin Gregg, Kevin J Weatherwax
Real-World Data Collection from Expanded Access Case Studies for the Treatment of Nontuberculous Mycobacterial Infection with Clofazimine. medRxiv : the preprint server for health sciences (2023)
Misty Gravelin, Joan E Adamo, Sharon Ellison, Erika Segear, Amanda B Parrish, Christine Deeter, Jennifer Hamill, Laurie Rigan, George A Mashour, Kevin J Weatherwax
National landscape assessment of academic medical center support for expanded access to investigational products. Journal of clinical and translational science 7 (1) (2022)
Elias M Samuels, Ellen Champagne, Misty Gravelin, Jamie Racklyeft, Kevin J Weatherwax
Adapting an Expanded Access program to enable investigational treatments for COVID-19. Journal of clinical and translational science 6 (1) (2022)
Misty Gravelin, Joan E Adamo, Sharon Ellison, Erika Segear, Amanda B Parrish, Christine Deeter, Jennifer Hamill, Laurie Rigan, George A Mashour, Kevin J Weatherwax
National landscape assessment of academic medical center support for expanded access to investigational products. Journal of clinical and translational science 7 (1) (2022)
Misty Gravelin, Jeanne Wright, M E Blair Holbein, Marlene Berro, Jennifer Swanton Brown, George A Mashour, Kevin J Weatherwax
Role of CTSA institutes and academic medical centers in facilitating preapproval access to investigational agents and devices during the COVID-19 pandemic. Journal of clinical and translational science 5 (1) (2021)